Pioglitazone Prevents Alcohol-Induced Fatty Liver in Rats Through Upregulation of c-Met

Gastroenterology

Volumn 126, Issue 3, 2004, Pages 873-885

  Tomita, Kengo ^a   Azuma, Toshifumi ^a   Kitamura, Naoto ^a   Nishida, Jiro ^b   Tamiya, Gen ^c   Oka, Akira ^c   Inokuchi, Sayaka ^a   Nishimura, Takeshi ^a   Suematsu, Makoto ^a   Ishii, Hiromasa ^a,d  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

^c TOKAI UNIVERSITY   (Japan)

^d KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DNA; PIOGLITAZONE; RNA;

ALCOHOL LIVER CIRRHOSIS; ALCOHOL METABOLISM; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DNA SYNTHESIS; DRUG EFFECT; DRUG HALF LIFE; FATTY LIVER; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIPID PEROXIDATION; LIPOGENESIS; LIVER CELL CULTURE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 10744221756     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.12.008     Document Type: Article

References (39)

1. Sorensen TI, Orholm M, Bentsen KD, Hoybye G, Eghoje K, Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984;2:241-4.
2. Teli MR, Day CP, Burt AD, Bennett MK, James OFW. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995;346:987-990.
3. Lin HA, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 2000;6:998-1003.
4. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167-1174.
5. Shimabukuro M, Zhou YT, Lee Y, Unger RH. Troglitazone lowers islet fat and restores beta cell function of Zucker Diabetic Fatty rats. J Biol Chem 1998;273:3547-3550.
6. Higa M, Zhou YT, Ravazzola M, Baetens D, Orci L, Unger RH. Troglitazone prevents mitochondrial alterations, β-cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci U S A 1999;96:11513-11518.
7. Kakuma T, Lee Y, Higa M, Wang ZW, Pan W, Shimomura I, Unger RH. Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci U S A 2000;97:8536-8541.
8. Scheen AJ. Hepatotoxicity with thiazolidinediones: Is it a class effect? Drug Saf 2001;24:873-888.
9. Lieber CS, DeCarli LM, Sorrell MF. Experimental methods of ethanol administration. Hepatology 1989;10:501-510.
10. Maeshida Y, Kiyota Y, Yoshimura Y, Motohashi M, Tanayama S. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys. Arzneim.-Forsch/Drug Res 1997;47:29-35.
11. Hayakawa T, Shiraki T, Morimoto T, Shii K, Ikeda H. Pioglitazone Improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats. Biochem Biophys Res Commun 1996;223:439-444.
12. Horikoshi H, Yoshioka T, Kawasaki T, Nakamura K, Matsunuma N, Yamaguchi K, Sasahara K. Troglitazone (CS-045), a new antidiabetic drug. Annu Rep Sankyo Res Lab 1994;46:1-57.
13. Tahara M, Matsumoto K, Nukiwa T, Nakamura T. Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats. J Clin Invest 1999;103:313-320.
14. Bachorik PS, Ross JW. National cholesterol education program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. Clin Chem 1995;41:1414-1420.
15. Hatch FT, Lees RS. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 1968;6:1-68.
16. Tomita K, Sato M, Kajiwara K, Tanaka M, Tamiya G, Makino S, Tomizawa M, Mizutani A, Kuwano Y, Shiina T, Ishii H, Kimura M. Gene structure and promoter for Crad2 encoding mouse cis-retinol/3α-hydroxysterol short-chain dehydrogenase isozyme. Gene 2000;251:175-186.
17. Dunn JCY, Yarmush ML, Koebe HG, Tompkins RG. Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J 1989;3:174-177.
18. Lawrence JM, Reckless JP. Actos (pioglitazone): a new treatment for type 2 diabetes. Hosp Med 2001;62:411-416.
19. Pelizzari CA, Khodarev NN, Gupta N, Calvin DP, Weichselbaum RR. Quantitative analysis of DNA array autoradiographs. Nucleic Acids Res 2000;28:4577-4581.
20. Tenenbaum SA, Carson CC, Lager PJ, Keene JD. Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc Natl Acad Sci U S A 2000;97:14085-14090.
21. Okada T, Mizoi Y. Studies on the problem of blood acetaldehyde determination in man and level after alcohol intake. Jpn J Alcohol Drug Depend 1982;17:141-159.
22. Wright HM, Clish CB, Mikami T, Hauser S, Yanagi K, Hiramatsu R, Serhan CN, Spiegelman BM. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation. J Biol Chem 2000;275:1873-1877.
23. Levine JA, Harris MM, Morgan MY. Energy expenditure in chronic abuse. Eur J Clin Invest 2000;30:779-786.
24. Eaton S, Record CO, Bartlett K. Multiple biochemical effects in the pathogenesis of alcoholic fatty liver. Eur J Clin Invest 1997;27:719-722.
25. Michalopoulos GK, Defrances MC. Liver regeneration. Science 1997;276:60-66.
26. Stuart KA, Riordan SM, Lidder S, Crostella L, Williams R, Skouteris GG. Hepatocyte growth factor/scatter factor-induced intracellular signaling. Int J Exp Pathol 2000;81:17-30.
27. Takehara T, Nakamura T. Protective effect of hepatocyte growth factor on in vitro hepatitis in primary cultured hepatocytes. Biomed Res 1991;12:335-338.
28. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotropic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992;16:1227-1235.
29. Kaibori M, Kwon AH, Oda M, Kamiyama Y, Kitamura N, Okumura T. Hepatocyte growth factor stimulates synthesis of lipids and secretion of lipoproteins in rat hepatocytes. Hepatology 1998;27:1354-1361.
30. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Song Y, Cohen P, Friedman JM, Attie AD. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A 2002;99:11482-11486.
31. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM, Friedman JM. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002;297:240-243.
32. Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 1998;273:35299-35306.
33. You M, Fischer M, Deeg MA, Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 2002;277:29342-29347.
34. Sato S, Kaido T, Yamaoka S, Yoshikawa A, Arii S, Nakamura T, Niwano M, Imamura M. Hepatocyte growth factor prevents lipopolysaccharide-induced hepatic sinusoidal endothelial cell injury and intrasinusoidal fibrin deposition in rats. J Surg Res 1998;80:194-199.
35. Letteron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 1996;24:200-208.
36. Kyokane T, Norimizu S, Taniai H, Yamaguchi T, Takeoka S, Tsuchida E, Naito M, Nimura Y, Ishimura Y, Suematsu M. Carbon monoxide from heme catabolism protects against hepatobiliary dysfunction in endotoxin-treated rat liver. Gastroenterology 2001;120:1227-1240.
37. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, Kitajima M, Makino N, Ishimura Y, Suematsu M. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res 1999;85:663-671.
38. Yamamoto Y, Nakajima M, Yamazaki H, Yokoi T. Cytotoxicity and apoptosis produced by troglitazone in human hepatoma cells. Life Sci 2001;70:471-482.
39. Imber CJ, Peter SDS, Handa A, Friend PJ. Hepatic steatosis and its relationship to transplantation. Liver Transpl 2002;8:415-423.